KT&G Launches Limited Edition "Raison Ionia 3 in 1" at Airports

Business by 2FIRSTS.ai
Sep.12.2024
KT&G Launches Limited Edition "Raison Ionia 3 in 1" at Airports
KT&G launches limited edition "Raison Ionia 3 in 1" cigarettes at Korean airports, catering to duty-free shoppers with new flavors.

According to N. News on September 12th, South Korean tobacco company KT&G announced that they will be offering limited quantities of the "Raison Ionia 3 in 1" product at airport duty-free shops.

 

This limited edition product is exclusively designed for airport duty-free shops, including three new varieties of cigarettes called "Raison Ionia". Each carton contains 10 packs, with 4 packs of Ocean Blue, 3 packs of Mystical Purple, and 3 packs of Summer Red. The price is $31 per carton, and the product is available at duty-free shops in five airports: Incheon, Gimpo, Gimhae, Daegu, and Jeju.

 

The "Raison Ionia" cigarette contains 4% tobacco, with each cigarette having tar and nicotine levels of 0.1 milligrams and 0.01 milligrams, respectively.

 

The head of KT&G Raison team, Gong Jeong-ho, stated,

 

In order to meet the needs of airport consumers, we have launched a limited edition "Raison Ionia" containing three new products. In the future, we will continue to introduce products that meet the needs and trends of consumers to enhance brand satisfaction.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai
EU to consider Denmark's proposal for stricter tobacco tax reforms. Heating tobacco tax could increase by 132%, nicotine pouch tax by up to 1000%. 92% opposed to overall tax hike in public consultation. Concerns raised over taxing innovative smoke-free pr
EU to consider Denmark's proposal for stricter tobacco tax reforms. Heating tobacco tax could increase by 132%, nicotine pouch tax by up to 1000%. 92% opposed to overall tax hike in public consultation. Concerns raised over taxing innovative smoke-free pr
EU to debate Denmark's proposal to increase tobacco taxes, including a 132% hike for heated tobacco and 1000% for nicotine pouches.
Dec.04 by 2FIRSTS.ai
KT&G Nears ASF Acquisition, Preparing Wide Regional Nicotine Pouch Expansion
KT&G Nears ASF Acquisition, Preparing Wide Regional Nicotine Pouch Expansion
South Korean outlet nate reports that KT&G expects to finalize its acquisition of Nordic nicotine pouch maker ASF within this year. Beginning next year, the company plans to expand the business well beyond ASF’s current five Nordic markets to Europe, the Middle East, Africa, Asia and North America, supported by its cooperation framework with Altria.
Nov.25
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco (JT) announced that Ploom AURA has added a second limited-edition colorway, “Bronze Royal,” which will be available in limited quantities through official channels starting November 11, priced at approximately $27.3.
Nov.12 by 2FIRSTS.ai
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
E-cigarette brand SKE has listed its “30K Pro Max” bundle across multiple UK e-commerce platforms. The 2-in-1 device features dual flavors with a twist-to-switch design, draw activation, and mesh heating, with a claimed total of up to 30,000 puffs. Across several channels, single-unit pricing ranges from about £8.99 to £10.99.
Oct.24 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21